November 21, 2026

Glaxo bowel drug linked to array of side effects

GlaxoSmithKline and its partner Adolor said on Monday their drug to treat gastrointestinal side effects of opioid painkillers was linked to higher risk of heart attacks and other serious heart problems, fractures and skin cancers in a late-stage trial.

bdnews24.com News Service

bdnews24.com

Published : 10 Apr 2007, 12:09 PM

Updated : 17 Aug 2022, 02:52 PM

NEW YORK, April 10 (bdnews24.com/Reuters) - GlaxoSmithKline and its partner Adolor said on Monday their drug to treat gastrointestinal side effects of opioid painkillers was linked to higher risk of heart attacks and other serious heart problems, fractures and skin cancers in a late-stage trial. The drugmakers said the negative findings came from a year-long Phase III study of their experimental drug, alvimopan, involving 805 patients experiencing bowel dysfunction as a result of taking opioids for treatment of chronic non-cancer pain. bdnews24.com/mir/1345 h
Related Stories